As of 10:25am ET
| -0.142 / -0.29%|
The 18 analysts offering 12-month price forecasts for Novozymes A/S have a median target of 47.19, with a high estimate of 54.70 and a low estimate of 38.68. The median estimate represents a -3.40% decrease from the last price of 48.85.
The current consensus among 18 polled investment analysts is to Hold stock in Novozymes A/S. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.